Syndax Pharmaceuticals Inc (SNDX)
Free Cash Flow
-$220.87M
TTM · Period ending: · USD
SNDX Free Cash Flow
Latest reported-$220.87Mperiod ending
Latest reported-$220.87Mperiod ending
SNDX TTM Free Cash Flow (-$7.33M → -$220.87M)
TTM free cash flow
High-resolution chart · PNG
SNDX free cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Free Cash Flow (USD) |
|---|---|
| -220,867,000 | |
| -278,350,000 | |
| -323,167,000 | |
| -311,011,000 | |
| -302,667,000 | |
| -286,517,000 | |
| -274,903,000 | |
| -258,864,000 | |
| -241,195,000 | |
| -204,921,000 | |
| -160,601,000 | |
| -142,146,000 | |
| -126,037,000 | |
| -130,972,000 | |
| -133,675,000 | |
| -10,201,000 | |
| -6,601,000 | |
| 9,660,000 | |
| 29,002,000 | |
| -87,209,000 | |
| -80,562,000 | |
| -77,924,000 | |
| -71,260,000 | |
| -68,356,000 | |
| -58,588,000 | |
| -49,706,000 | |
| -50,612,000 | |
| -52,942,000 | |
| -62,882,000 | |
| -65,506,000 | |
| -68,718,000 | |
| -66,425,000 | |
| -58,179,000 | |
| -54,830,000 | |
| -47,455,000 | |
| -45,107,000 | |
| -46,387,000 | |
| -41,550,000 | |
| -35,418,000 | |
| -29,328,000 | |
| -23,020,000 | |
| -20,058,000 | |
| -2,477,000 | |
| -1,630,000 | |
| 963,000 | |
| 1,160,000 | |
| -14,397,000 | |
| -13,704,000 | |
| -13,237,000 | |
| -10,360,000 | |
| -7,333,000 | |
| -4,548,065 |